Young Research & Publishing Inc.

Investment Research Since 1978

Disclosure

  • About Us
    • Contributors
    • Archives
    • Dick Young’s Safe America
    • The Final Richard C. Young’s Intelligence Report
    • You’ve Read The Last Issue of Intelligence Report, Now What?
    • Dick Young’s Research Key: Anecdotal Evidence Gathering
    • Crisis at Vanguard
  • Investment Analysis
    • Bonds
    • Currencies and Gold
    • Dividend Investing
    • ETFs & Funds
    • Investment Strategy
    • Retirement Investing
    • Stocks
    • The Efficient Frontier
  • Investment Counsel
  • Retirement Compounders®
  • Free Email Signup

Amazon Makes Move in Pharmacy

June 29, 2018 By Jeremy Jones, CFA

By Pavel Kubarkov @ Shutterstock.com

Amazon announced yesterday that it is buying Pillpack. Pillpack is an innovative little company that pre-packages medicines for consumers who take multiple drugs regularly. The big pharmacy stocks predictably sold-off on the news that big-bad Amazon is entering their business, but there is much less to be concerned about than meets the eye.

Selling prescription drugs is much different than selling Amazon Kindles. A quick review of the Pillpack website shows that. It takes 10-15 minutes to even signup. There is insurance that needs to be dealt with, regulation, pharmacy benefits managers, and there is back and forth between doctors and pharmacies when drugs are prescribed.

And don’t forget about the competitive response Amazon is likely to face from this move. CVS is in the process of merging with health insurer Aetna. Guess which insurer probably won’t include Pillpack in their pharmacy network.

The share price performance of the two big pharmacies is unfortunate if you are a value conscious investor. The pharmacy stocks are among the most attractively priced in the market today. The market’s obsession with FAANG stocks has led to investor overreaction on every move the FAANGs make.

Take retail shares for example. The performance of the SPDR retail ETF over the last twelve months is instructive. The SPDR retail ETF was down as much as 25% from its 2015 high (with many individual retailers down much more) on concern that Amazon was going to bankrupt every brick and mortar business in America. Sentiment on the sector was rotten last summer and fall, but from its lows of last year, the SPDR Retail ETF is up 30% with many individual retailers up much more.

Or take WW Grainger. Grainger is in the industrial supply business. They have a big online presence and Amazon is gunning for them. Grainger even had to cut prices to stay competitive. The stock was down as much as 33% last year during the height of the concern, but the shares have almost doubled since and now trade at a new high. And Amazon is a much more serious competitor to Grainger than it is to the big pharmacies.

Savvy, seasoned, patient investors might anticipate a similar sentiment reversal in CVS and Walgreens shares.

Share this:

  • Email
  • Twitter
  • Facebook

You Might Also Like:

  • Are Retail Stocks at an Inflection Point?
  • Amazon Keeps Expanding
  • Kroger Gunning for Amazon
  • Author
  • Recent Posts
Jeremy Jones, CFA
Jeremy Jones, CFA, CFP® is the Director of Research at Young Research & Publishing Inc., and the Chief Investment Officer at Richard C. Young & Co., Ltd. CNBC has ranked Richard C. Young & Co., Ltd. as one of the Top 100 Financial Advisors in the nation (2019-2022) Disclosure. Jeremy is also a contributing editor of youngresearch.com.
Latest posts by Jeremy Jones, CFA (see all)
  • Money Market Assets Hit Record High: $5.4 Trillion - May 26, 2023
  • The Mania in AI Stocks Has Arrived - May 25, 2023
  • The Wisdom of Sam Zell - May 24, 2023

Search Young Research

Most Popular

  • Letter to the Federal Reserve Chairman from Your Survival Guy
  • What Does That Have to Do with Your Dividend?
  • Is an Investment Property Disaster Looming?
  • “I Came from Nothing,” He Said. “I Mean Nothing.”
  • Private Debt Funds: More Risk than Meets the Eye
  • The Wisdom of Sam Zell
  • How Activists Have Weaponized Corporate Boards
  • Is Japan Rising Once More?
  • Vanguard Wellesley (VWINX) vs. Wellington (VWELX): Which Fund is Best?
  • When Did You Become Serious about Your Money?

Don’t Miss

Default Risk Among the Many Concerns with Annuities

Risk and Reward: An Efficient Frontier

How to be a Billionaire: Proven Strategies from the Titans of Wealth

Cryptocosm and Life After Google

Warning: Avoid Mutual Fund Year End Distributions

Is Gold a Good Long-term Investment?

How to Invest in Gold

Vanguard Wellington (VWELX): The Original Balanced Fund

What is the Best Gold ETF for Investing and Trading?

Procter & Gamble (PG) Stock: The Only True Dividend King

The Dividend King of the North

You’ll Love This if You’re Dreaming of an Active Retirement Life

The Importance of a Balanced Portfolio

Invest with Peace of Mind and Comfort

What Kind of Life Are You Investing For?

RSS The Latest at Richardcyoung.com

  • Pushing the Envelope Too Far
  • Your Survival Guy in Rome 30-Years A.B. (After Babson)
  • America’s Favorite Wordsmith Needs Tutoring
  • A Three-Week International Research Trip to Paris via Rome
  • BIOTERROR RISK: The Dangers Genetically Modified Insects
  • Why Be Proud?
  • What Does That Have to Do with Your Dividend?
  • Will Biden’s Ukraine Gambit Be America’s Worst Foreign Policy Disaster?
  • Stossel Says DeSantis Is “Smarter and Better than Biden.”
  • What Would They Give Up for “Equity”?

RSS The Latest at Yoursurvivalguy.com

  • Your Survival Guy in Rome 30-Years A.B. (After Babson)
  • Insurers Now Fleeing the Net Zero Insurance Alliance
  • A Three-Week International Research Trip to Paris via Rome
  • Will Biden Repeat Obama with US Debt Downgrade?
  • What Does That Have to Do with Your Dividend?
  • The ESG Cartel
  • Two More States Nearing Passage of Permitless Carry Legislation
  • How Activists Have Weaponized Corporate Boards
  • Letter to the Federal Reserve Chairman from Your Survival Guy
  • Big Blue Blob Cities Get Bad News from Census Report

About Us

  • About Young Research
  • Archives
  • Contributors

Our Partners

  • Richard C. Young & Co.
  • Richardcyoung.com

Copyright © 2023 | Terms & Conditions

 

Loading Comments...
 

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.